HUTCHMED (China) Ltd
LSE:HCM
HUTCHMED (China) Ltd
LSE:HCM
Price:
295 GBX
-1.67%
Market Closed
Updated:
May 29, 2024
HUTCHMED (China) Ltd
Operating Expenses
|
HUTCHMED (China) Ltd
Operating Expenses Peer Comparison
Comparables:
G
512
U
3933
1177
C
570
C
3320
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
HUTCHMED (China) Ltd
LSE:HCM
|
Operating Expenses
-$435.2m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-33%
|
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
Operating Expenses
-HK$3.7B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-18%
|
|
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
Operating Expenses
-¥3.1B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-6%
|
|
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Operating Expenses
-¥15.3B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-13%
|
|
C
|
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
|
Operating Expenses
-¥7.9B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-30%
|
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Operating Expenses
-HK$26.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
See Also
What is HUTCHMED (China) Ltd's Operating Expenses?
Operating Expenses
-435.2m
USD
-435.2m
USD
Based on the financial report for Dec 31, 2023, HUTCHMED (China) Ltd's Operating Expenses amounts to -435.2m USD.
What is HUTCHMED (China) Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-33%
-33%
Over the last year, the Operating Expenses growth was 17%. The average annual Operating Expenses growth rates for HUTCHMED (China) Ltd have been -23% over the past three years , -22% over the past five years , and -33% over the past ten years .
You don't have any saved screeners yet
